Integral Diagnostics | IDX - Fremdkapital

Aktienkurs
2.35
Täglich Wechseln
-0.06 -2.49%
Monatlich
-2.49%
Jährlich
1.73%
Q1 Prognose
2.30




Fremdkapital Veränderung Datum
Alcidion AUD 318K 376K 2025-12
Ansell USD 751.6M 113.1M 2025-12
Cochlear AUD 200M 6.5M 2025-12
CSL USD 10.42B 273M 2025-12
Healius AUD 1.22B 103M 2024-12
Mayne Pharma AUD 2.66M 153K 2025-06
Monash IVF AUD 186.73M 16.17M 2025-12
Nanosonics AUD 3.21M 1.06M 2025-12
Polynovo AUD 15.39M 663K 2025-12
Ramsay Health Care AUD 11.2B 5.74B 2025-12
ResMed USD 403.92M 4.74M 2025-12
Sigma Healthcare AUD 1.88B 1.75B 2025-12
Sonic Healthcare AUD 4.19B 333.39M 2024-12
Telix Pharmaceuticals AUD 448.45M 76.97M 2025-12